WCT:NASDAQWellchange Holdings Company Limited Analysis
Data as of 2026-05-10 - not real-time
$2.14
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Wellchange Holdings (WCT) is under severe pressure – the stock trades at $2.14, well below its 20‑day ($2.17), 50‑day ($2.99) and 200‑day ($9.33) simple moving averages, and the RSI sits at 39, indicating a lack of buying momentum. Technicals are mixed: while the MACD histogram is slightly positive, the overall trend is bearish with decreasing volume and a 30‑day volatility of over 110%, compounded by a beta of 2.08, suggesting the share price is highly sensitive to market swings.
Fundamentally the picture is bleak: the company reports negative operating and profit margins, a massive EBITDA loss, and a cash burn exceeding $9.5 M against only $71 k of cash on hand. Debt is crushing – a debt‑to‑equity ratio above 4 and a max drawdown of roughly –91% highlight financial distress. The book‑value discount (P/B ≈ 0.18) is offset by the lack of earnings and a pending securities class‑action investigation, adding significant regulatory risk.
Fundamentally the picture is bleak: the company reports negative operating and profit margins, a massive EBITDA loss, and a cash burn exceeding $9.5 M against only $71 k of cash on hand. Debt is crushing – a debt‑to‑equity ratio above 4 and a max drawdown of roughly –91% highlight financial distress. The book‑value discount (P/B ≈ 0.18) is offset by the lack of earnings and a pending securities class‑action investigation, adding significant regulatory risk.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below all major moving averages and low RSI
- Negative earnings, cash flow, and high leverage
- Ongoing securities class‑action investigation
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained bearish technical environment
- Continued financial distress with no clear turnaround
- Elevated volatility and beta amplifying market risk
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Fundamental deficits unlikely to improve without major restructuring
- High regulatory and legal exposure
- Liquidity constraints and thin trading volumes
Key Metrics & Analysis
Financial Health
Revenue Growth12.90%
Profit Margin-154.47%
ROE-51.28%
ROA-30.01%
Debt/Equity4.35
P/B Ratio0.2
Op. Cash Flow$-9588530
Free Cash Flow$-6927292
Industry P/E38.4
Technical Analysis
TrendBearish
RSI39.2
Support$1.58
Resistance$2.90
MA 20$2.17
MA 50$2.99
MA 200$9.33
MACDBullish
VolumeDecreasing
Fear & Greed Index90.73
Valuation
GradeFair
TypeValue
Risk Assessment
Beta2.08
Volatility110.81%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.